2017-AACR-Aberrant nuclear expression of GSK-3β in human head and neck carcinoma
2017-AACR-Aberrant nuclear expression of GSK-3β in human head and neck carcinoma Read More »
Search Results for: F
DR. FRANCIS GILES JOINS ACTUATE THERAPEUTICS AS CHIEF MEDICAL OFFICER
CHICAGO, IL and FORT WORTH, TX, March 1, 2017 – Actuate Therapeutics, Inc., a Chicago-based biopharmaceutical company, today announced the appointment of Francis J. Giles, MB, MD, FRCPI, FRCPath to the newly created position of Chief Medical Officer (CMO). Dr. Giles will be responsible for advancing Actuate’s research and development initiatives, leading the clinical programs,
DR. FRANCIS GILES JOINS ACTUATE THERAPEUTICS AS CHIEF MEDICAL OFFICER Read More »